Details for Patent: 6,369,085

✉ Email this page to a colleague

Summary for Patent: 6,369,085

Title:	Form of S-omeprazole
Abstract:	The present invention relates to a novel form of the (-)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-ben zimidazole, i.e. S-omeprazole. More specifically, it relates to a novel form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The present invention also relates to processes for preparing such a form of the magnesium salt of S-omeprazole and pharmaceutical compositions containing it. Furthermore, the present invention also relates to new intermediates used in the process.
Inventor(s):	Cotton; Hanna (Sodertalje, SE), Kronstrom; Anders (Sodertalje, SE), Mattson; Anders (Sodertalje, SE), Moller; Eva (Sodertalje, SE)
Assignee:	AstraZeneca AB (Sodertalje, SE)
Application Number:	09/077,719
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,369,085
Patent Claim Types: see list of patent claims	Compound; Use; Process; Composition;

Drugs Protected by US Patent 6,369,085

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,369,085

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Sweden	9702065	May 30, 1997

PCT Information
PCT Filed	May 05, 1998	PCT Application Number:	PCT/SE98/00974
PCT Publication Date:	December 03, 1998	PCT Publication Number:	WO98/54171

International Family Members for US Patent 6,369,085

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	0984957	⤷ Sign Up	PA2011005	Lithuania	⤷ Sign Up
European Patent Office	0984957	⤷ Sign Up	C300483	Netherlands	⤷ Sign Up
European Patent Office	0984957	⤷ Sign Up	91871	Luxembourg	⤷ Sign Up
European Patent Office	0984957	⤷ Sign Up	C300517	Netherlands	⤷ Sign Up
European Patent Office	0984957	⤷ Sign Up	CA 2012 00008	Denmark	⤷ Sign Up
European Patent Office	0984957	⤷ Sign Up	92017	Luxembourg	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.